NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹16 Cr | ₹7.22 Cr | ₹7.61 Cr | ₹10 Cr | ₹12 Cr |
What is the latest Long Term Provisions ratio of NEULAND LABORATORIES ?
| Year | Long Term Provisions |
|---|---|
| Mar2026 | ₹16 Cr |
| Mar2025 | ₹7.22 Cr |
| Mar2024 | ₹7.61 Cr |
| Mar2023 | ₹10 Cr |
| Mar2022 | ₹12 Cr |
How is Long Term Provisions of NEULAND LABORATORIES Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹16 Cr | 119.62 | |
| Mar2025 | ₹7.22 Cr | -5.10 | |
| Mar2024 | ₹7.61 Cr | -26.05 | |
| Mar2023 | ₹10 Cr | -13.62 | |
| Mar2022 | ₹12 Cr | - | |
Compare Long Term Provisions of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹29,345.4 Cr | -1.7% | 23.5% | 72.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹458,249.0 Cr | 1.8% | -1.6% | 16.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | -1.2% | 17.3% | 38.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,891.0 Cr | -2.3% | -2% | 33.6% | Stock Analytics | |
| CIPLA | ₹115,927.0 Cr | 0.2% | 1.7% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,702.0 Cr | 1.2% | 3.6% | -7% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -1.7% |
23.5% |
72.1% |
| SENSEX | -0.5% |
1.3% |
-4% |
You may also like the below Video Courses